Timothy R. McGuire, Pharm.D., FCCP

Associate Professor

Department of Pharmacy Practice
College of Pharmacy
University of Nebraska Medical Center
986045 Nebraska Medical Center
Omaha, NE 68198-6045
402-559-8224 (Office)
402-559-4614 (Lab)
402-559-5673 (Fax)
trmcguir@unmc.edu
 
Teaching Activities:
Dr. McGuire delivers lectures in several team taught courses, including anemia lectures in Pharmacotherapy I (PHPR 684) and oncology lectures in Pharmacotherapy III (PHPR 688). He also gives lectures on cancer chemotherapy for the graduate level course Biochemistry 880. Dr. McGuire serves as a preceptor for the Oncology clerkships.
 
Research Activities/Interests: 
Dr. McGuire's major interest is investigating the damaging effects of inflammatory cytokines after stem cell transplantation. He also has interest in public health research where it has been attempted to develop community pharmacies as sites for public health education and intervention. Dr. McGuire is a co-investigator in the antineoplastic pharmacology laboratory and has ongoing research investigating the optimal use of anti-cancer drugs in cancer patients.
 
Recent Publications:

  1. Kazakoff PW, McGuire TR, Hoie EB, Iversen PL. An in vitro model for endothelial permeability: Assessment of monolayer integrity. In vitro 1995;31:846-852.
  2. McGuire TR, Kazakoff PW, Hoie EB, Fienhold MA. Antiproliferative activity of shark cartilage with and without tumor necrosis factor-alpha in human umbilical vein endothelium. Pharmacotherapy 1996;16:237-244.
  3. Manouilov KK, McGuire TR, Gwilt PR. Colorimetric determination of hydroxyurea in human serum using high-performance liquid chromatography. J Chromatogr 1998;708:321-324.
  4. Manouilov KK, McGuire TR, Gordon BG, Gwilt PR. Assay for etoposide in human serum using solid-phase extraction and high-performance liquid chromatography with fluorescence detection. J Chromatogr 1998;707:342-346.
  5. McGuire TR, Kessinger MA, Hock L, Sharp G. Elevated transforming growth factor beta levels in the plasma of cytokine treated cancer patients and normal allogeneic stem cell donors. Cytotherapy 2001 (in press)

Tim McGuire, Pharm.D.
Dr. McGuire